Key result
Antiviral and traditional medicine regimen achieves 100% cardiopulmonary recovery and safe return to play in athletes.
Why the study?
Under normalized epidemic conditions, how athletes safely train and compete remained an important open question.
Case Report (n=7)
No
Strict closed-loop epidemic countermeasures, combined medical therapy, extended '14+14' quarantine, and serial cardiopulmonary evaluations enabled elite athletes with mild-to-moderate COVID-19 to safely return to championship-level competition without cardiac sequelae or team transmission.
Answers are grounded in this paper and cite their sources.
Supports safe RTP protocols after mild COVID-19 in athletes; leaves open efficacy of combined therapies in larger controlled studies.
Under the condition of normalized epidemic, how athletes train and compete well has been in the spotlight. This article reported the symptom, hospitalization and training situation of seven confirmed cases of coronavirus-disease-2019 (COVID-19) among Chinese national teams. Moreover, the paper summarized the experience of Chinese national teams in terms of epidemic prevention and control, treatment of infection, and safe return to play. Through a scientific combination of medication and non-medical treatment, seven athletes were all discharged from the hospital. These discharged athletes underwent strict isolation and scientific training before returning to sports teams. Before returning to play, continuous monitoring of physical and mental condition was required. All seven athletes returned to play safely and performed excellently. As for hosting large-scale sporting events, the entire enclosed-loop management from immigration to competition was proposed in this paper. This study could serve as a standard of epidemic prevention and control, treatment for infection and safe return to play during competition and training around the world.
No takes yet. Share an insight, caveat, or question.
Zhan et al. (2021) conducted a case report in COVID-19 infection in elite national team athletes (n=7). Comprehensive COVID-19 medical treatment (interferon-alpha, lopinavir/ritonavir, vitamin B1, traditional Chinese medicine), 14+14 day post-discharge quarantine, and structured return-to-play monitoring was evaluated on Hospital discharge, nucleic acid negative conversion, cardiopulmonary recovery, and return to play. Combined antiviral and traditional Chinese medicine therapy with structured quarantine enabled all 7 athletes to recover without organic cardiopulmonary injury and return to play at mean 70.9 days.
Synapse has enriched 10 related papers. Consider them for comparative context: